跳至主要内容
临床试验/NCT05649904
NCT05649904招募中不适用

Use of Active Fluid Exchange to Therapeutically Treat Intracranial Bleeding and Infection

Ohio State University2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2023年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
240
试验地点
2
主要终点
Rate of revision procedures for the IRRAflow and EVD/Drainage catheters

研究概览

简要总结

The goal of this clinical trial is to evaluate efficacy and safety of evacuation of cerebrospinal fluid, blood, and harmful bacteria from the intraventricular, subdural and subarachnoid spaces by Active Controlled Irrigation and Drainage (IRRAflow) compared to Passive External Ventricular Drainage (EVD).

Subjects with intraventricular hemorrhage, subarachnoid hemorrhage, subdural bleeding, and ventriculitis will be randomized to receive the IRRAflow device or EVD device and followed for one month post-procedure to compare outcomes between the subject groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years of age
  • Need of drainage for one of the following underlying conditions: Intraventricular hemorrhage, intracranial hemorrhage, subarachnoid hemorrhage, chronic subdural hematoma and ventriculitis
  • Indication for active treatment evaluated by treating physician for underlying conditions; Intraventricular hemorrhage, subarachnoid hemorrhage, chronic subdural hematoma and ventriculitis
  • Signed informed consent obtained by subject or Legally Authorized Representative

排除标准

  • Subject has fixed and dilated pupils
  • Pregnant women
  • Presence of Moyamoya
  • History or presence of clotting disorder.
  • Platelet count less than 100,000, INR greater than 1.4

结局指标

主要结局

Rate of revision procedures for the IRRAflow and EVD/Drainage catheters

时间窗: Immediately post-procedure

次要结局

  • Indwell time of EVD/Drainage and IRRAflow Catheter(Immediately post-procedure)
  • Length of ICU stay(Baseline)
  • Rate of shunt dependency(Immediately post-procedure)
  • Time to clearance of blood or bacterial mass as measured by head CT scan(Immediately post-procedure)
  • Mortality rates - intraprocedural and at 30 days(30 days post subject discharge)
  • Rate of catheter-related infection(Immediately post-procedure)
  • Functional Status - at inclusion and 30 days(30 days post subject discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Patrick Youssef

Clinical Assistant Professor of Neurological Surgery

Ohio State University

研究点 (2)

Loading locations...

相似试验